Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Mark Cuban ‘Very Involved’, Insists Generics Company CEO
As He Admits COVID-19 Accelerated Company Timeline
Jan 28 2021
•
By
Akriti Seth
The Mark Cuban Cost Plus Drug Company has been in the works since 2018 • Source: Shutterstock
More from Strategy
More from Business
